LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Top News  :  Lupin, Coromandel International and AstraZeneca to see some action today

Lupin, Coromandel International and AstraZeneca to see some action today (24-Jul-2017)

US Food and Drug Administration (USFDA) has successfully completed Prior Approval Inspection (PAI) at Lupin's Goa manufacturing facility without any observations. The inspection which started on July 17 concluded on July 21, 2017. Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Coromandel International has received environmental clearance for raising production capacity of its facility at Vishakhapatnam in Andhra Pradesh. The environment clearance to Rs 225-crore expansion project is subject to the compliance of specific and general conditions. The company's proposal is to raise phosphoric acid production capacity from 700 tonnes per day to 1,000 tonnes per day and other auxiliary facilities at Sriharipuram to achieve daily complex fertiliser production of 3,900 tonnes.

AstraZeneca Pharma India will be launching Osimertinib 40 mg and 80 mg (Tagrisso) in India on July 27, 2017. Osimertinib 40 mg and 80 mg (Tagrisso) is an oral anti-cancer drug for management of lung cancer. It is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an appropriate test, whose disease has progressed on or after EGFR TKI therapy. Osimertinib (Tagrisso) is the product of AstraZeneca group and has been approved in over 45 countries, including US, EU, Japan, China and other Asian countries.

Persistent Systems' wholly owned subsidiary in Germany namely, Persistent Systems Germany GmbH has entered into an agreement with PARX Werk AG, Switzerland (PARX) on July 21, 2017 to acquire PARX, a Salesforce Certified Platinum Partner in DACH region. The acquisition is subject to customary closing conditions which are expected to get completed within 3-4 weeks. The consideration would be in cash. The proposed acquisition strengthens Persistent's Salesforce practice through entry into new markets as well as provides new capabilities to support customers on their digital transformation initiatives.  

Vikas WSP has received export orders for an aggregate amount of Rs 119 crore for shipment of its newly developed guar gum product 'Thermo Guar-30' in the next two quarters. The company has already filed patent for the said product. Vikas WSP is one of India's foremost guar gum powder (GGP) manufacturer, supplying to all sectors of the food industry with an extensive range of quality products.

Speciality Restaurants has opened a new POH (Progressive Oriental House) restaurant at Mumbai. As continuation of the company's determination to dominate in Chinese and Pan Asian Market in India, the company has given birth to a new boutique oriental restaurant called Progressive Oriental House. This restaurant at Kamala Mills, Mumbai is targeted towards creme de la creme and HNI's, who are looking for newer flavours and experience.



Top News Today
Future Enterprises gets nod to raise funds up to Rs 1,500 crore
(26-May-2018)

Future Enterprises gets nod to raise funds up to Rs 1,500 croreFuture Enterprises has received its board's approval to raise funds by issue of Secured Redeemable Non-Convertible Debentures (NCDs) for a value up to Rs 1,500 crore in one or more tranches within a period......click on news to read complete article.

IFCI recovers Rs 280 crore from Bhushan Steel
(26-May-2018)

IFCI recovers Rs 280 crore from Bhushan SteelIFCI has recovered Rs 280 crore from debt-ridden Bhushan Steel under the insolvency process. The company also received over 5.79 lakh equity shares of Bhushan Steel, having face value of Rs 2 per share.IFCI......click on news to read complete article.

Sun Pharma reports 7% rise in Q4 consolidated net profit
(26-May-2018)

Sun Pharma reports 7% rise in Q4 consolidated net profitSun Pharmaceutical Industries has reported results for the fourth quarter and year ended March 31, 2018.The company has reported a rise of 83.30% in its net profit at Rs 176.26 crore for the quarter ended......click on news to read complete article.

International Stock News
US markets end mostly in red on Friday
(26-May-2018)

US markets end mostly in red on FridayThe US markets ended the choppy day of trade mostly in red terrain as some traders were away from their desks, looking to get a head start on the long Memorial Day weekend. Geopolitical uncertainty also......click on news to read complete article.

US markets end mostly in red on Friday
(26-May-2018)

US markets end mostly in red on FridayThe US markets ended the choppy day of trade mostly in red terrain as some traders were away from their desks, looking to get a head start on the long Memorial Day weekend. Geopolitical uncertainty also......click on news to read complete article.

US markets end lower on Thursday
(25-May-2018)

US markets end lower on ThursdayThe US markets ended in red terrain on Thursday, as geopolitical worries hovered over markets after Trump called off the summit that was set to take place June 12 in Singapore. The cancellation followed......click on news to read complete article.

 

     
  
Recent Top News News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.